medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 10

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (10)

Hereditary angioedema type III in pregnant women: case report and literature review

Luque-González P, Redondo-Villatoro A, Azcona-Sutil L, Carmona-Domínguez E, Félix-Santamaría C, Cabezas-Palacios MN
Full text How to cite this article

Language: Spanish
References: 21
Page: 810-817
PDF size: 184.29 Kb.


Key words:

Hereditary angioedema Type III, Adult, Pregnancy, Rare disease, Edema, Extremities, C1 inhibitor, Postpartum period.

ABSTRACT

Background: Hereditary angioedema is a rare disease characterized by recurrent episodes of edema anywhere in the body, especially in the extremities, face and airways. There are three types of the disease depending on its cause, the most infrequent being III with normal C1 inhibitor level and function. Its pathophysiology is poorly understood; therefore, its diagnosis is difficult. Its treatment has advanced in recent years, although much remains to be defined, especially during pregnancy.
Objective: To evaluate the available literature related to hereditary angioedema and its medical care in pregnant women.
Clinical case: 30-year-old female patient, during her first pregnancy. The only personal history of note was hereditary angioedema type III, diagnosed 10 years earlier after several episodes of orofacial angioedema. Throughout the pregnancy, several crises of the disease occurred, requiring treatment in acute episodes and maintenance treatment in the third trimester. Finally, one delivery was instrumented by vaccum, due to risk of loss of fetal well-being with good maternal and fetal outcome in the immediate postpartum period.
Conclusions: Hereditary angioedema type III is a very rare and little-known disease that requires establishing a protocol and standardization of clinical care, especially in pregnant women, which will help to provide quality information and assistance to these patients.


REFERENCES

  1. Salazar Torres L. Manejo del embarazo en pacientes con angioedema hereditario. Rev Cuba Obstetr Ginecol 2019; 45 (1). http://revginecobstetricia.sld.cu/index.php/gin/ article/view/294

  2. Longhurst H, Cicardi M, Craig T, Bork K, et al. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med 2017; 376 (12): 1131-40. doi: 10.1056/NEJMoa1613627

  3. Craig T, Zuraw B, Longhurst H, Cicardi M, et al. Long-term outcomes with subcutaneous c1-inhibitor replacement therapy for prevention of hereditary angioedema attacks. J Allergy Clin Immunol Pract 2019; 7 (6): 1793-802.e2. doi: 10.1016/j.jaip.2019.01.054

  4. Salazar Torres L, Díaz Marín C, Quintana Gómez F, Avila Gamboa D, et al. Angioedema hereditario y embarazo. Rev Latin Perinat 2016;19 (1). http://revperinatologia. com/images/1_Angioedema_hereditario_y_embarazo.pdf

  5. Ramos Nunes Estevens TM, Serrano A, Amaro S, Ribeiro J. Peri-operative management of a pregnant patient with hereditary angioedema submitted to a cesarean-section: case report. Rev Bras Anestesiol 2020; 70 (1): 48-50. doi: 10.1016/j.bjan.2019.10.003

  6. Riedl MA. Hereditary angioedema with normal C1-INH (HAE type III). J Allergy Clin Immunol Pract 2013; 1 (5): 427-32. doi: 10.1016/j.jaip.2013.06.004

  7. Banerji A. Hereditary angioedema: classification, pathogenesis, and diagnosis. Allergy Asthma Proc 2011; 32 (6): 403-7. doi: 10.2500/aap.2011.32.3492

  8. Martinez Saguer I, Escuriola Ettingshausen C. Successful management of hereditary angioedema during pregnancy in a patient with heterozygous MTHFR mutation. Ann Allergy Asthma Immunol 2017; 118 (6): 734-35. doi: 10.1016/j. anai.2017.04.001

  9. Bork K, Barnstedt SE, Koch P, Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000; 356 (9225): 213-7. doi: 10.1016/S0140- 6736(00)02483-1

  10. Moreno AS, Valle SOR, Levy S, França AT, et al. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor. Int Arch Allergy Immunol 2015; 166 (2): 114-20. doi: 10.1159/000376547

  11. Gibbons KR, Abraham T, Sandhu M, Peppers BP, et al. Successful perinatal management of hereditary angioedema with normal C1 esterase inhibitor and factor XII mutation using C1 esterase inhibitor therapy. Ann Allergy Asthma Immunol 2017; 119 (6): 558-59. doi: 10.1016/j. anai.2017.08.015

  12. Satomura A, Fujita T, Nakayama T. Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema. Intern Med 2018;57(5):751-755. doi: 10.2169/internalmedicine. 9407-17

  13. Betschel S, Badiou J, Binkley K, Borici-Mazi R, et al. The International/Canadian Hereditary Angioedema Guideline. Allergy Asthma Clin Immunol. 2019; 15: 72. doi: 10.1186/ s13223-019-0376-8

  14. De Maat S, Björkqvist J, Suffritti C, Wiesenekker CP, et al. Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations. J Allergy Clin Immunol 2016; 138 (5): 1414-1423. e9. doi: 10.1016/j.jaci.2016.02.021

  15. Stieber C, Cichon S, Magerl M, Nöthen MM. Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1). Eur J Hum Genet 2017; 25 (10): e1-e4. doi: 10.1038/ejhg.2017.104

  16. Banerji A, Riedl M. Managing the female patient with hereditary angioedema. Womens Health (Lond) 2016; 12 (3): 351-61. doi: 10.2217/whe.16.6

  17. Deroux A, Boccon-Gibod I, Fain O, Pralong P, et al. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema. Clin Exp Immunol 2016; 185 (3): 332-7. doi: 10.1111/cei.12820

  18. Oguma K, Suzuki T, Mano S, Takeuchi S, et al. Hereditary angioedema with deep vein thrombosis and pulmonary thromboembolism during pregnancy. Taiwan J Obstet Gynecol 2019; 58 (6): 895-96. doi: 10.1016/j. tjog.2019.04.003

  19. Loli-Ausejo D, Hernández-Martín I, Cabañas R, Entrala A, et al. Tranexamic Acid Plus Bemiparin Sodium as Long- Term Prophylaxis in a Patient With FXII-HAE During Pregnancy: A Case Report. J Investig Allergol Clin Immunol 2020; 30 (6): 464-65. doi: 10.18176/jiaci.0585

  20. Zornoza-García V, Luengo-Tabernero A, Caro-Floriano JDJ, Álvarez-Sierra V, et al. Angioedema hereditario en mujer embarazada con parto normal. Clin Invest Gin Obst 2009; 36 (5): 181-82. https://doi.org/10.1016/j. gine.2008.01.005

  21. Suárez González JA, Ojeda Blanco JC, Gutiérrez Machado M. Angioedema hereditario y embarazo. Rev Cuba Obstetr Ginecol 2016; 42 (3). http://revginecobstetricia.sld.cu/ index.php/gin/article/view/78




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2021;89